News for '-us-food'

Glenmark gets USFDA nod for drug

Glenmark gets USFDA nod for drug

Rediff.com19 Jun 2013

Riluzole is indicated for the treatment of amyotrophic lateral sclerosis.

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Sun Pharma hit by FDA ban on Gujarat plant, shares fall

Rediff.com13 Mar 2014

Recently, Ranbaxy and Wockhardt too were hauled up.

Indra Nooyi's views on US Prez

Indra Nooyi's views on US Prez

Rediff.com22 May 2008

PepsiCo CEO Indra Nooyi's efforts to promote equality of women in business goes way beyond designing a maternity deal, but when it comes to choosing the American President she says only the best will do regardless of gender or race.

Bloodbath on D-Street; Rs 6 lakh crore vanishes in 7 days

Bloodbath on D-Street; Rs 6 lakh crore vanishes in 7 days

Rediff.com27 Sep 2017

In the longest losing streak of 2017, the BSE Sensex has lost 1,270 points, or 3.91 per cent. It fell to a three-month low of 31,154.03 on Wednesday.

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Rediff.com27 Jun 2014

Ohm Laboratories Inc, a wholly-owned subsidiary of Ranbaxy has received approval from the US Food and Drug Administration for manufacturing and marketing Valsartan tablets in strengths of 40 mg, 80 mg, 160 mg, and 320 mg on an exclusive basis, Ranbaxy Laboratories said in a statement.

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

FDA warns India's Emcure Pharma, cites repeated data fudging at plant

Rediff.com17 Mar 2016

It is one of 42 drug-making factories in India that the FDA has banned in recent years

Lupin plans Rs 2bn expansion

Lupin plans Rs 2bn expansion

Rediff.com10 Aug 2007

Mumbai-based pharma major Lupin will invest over Rs 200 crore (Rs 2 billion) this year to create additional manufacturing capacities.

Indian pharma prefers non-litigation route in US

Indian pharma prefers non-litigation route in US

Rediff.com22 Nov 2007

The Indian pharmaceutical companies are involved in patent litigations of a mere 40 drugs, out of the 135 known patent litigation drugs in the US. This is despite the claims by major Indian players such as Ranbaxy and Dr Reddy's at having secured over 20 first to file status abbreviated new drug applications with the US Food and Drug Administration.

Australia suspends import of Maggi Noodles from India

Australia suspends import of Maggi Noodles from India

Rediff.com15 Jun 2015

Maggi has also come on the radar of US Food and Drug Administration.

Ranbaxy, US co in licensing deal

Ranbaxy, US co in licensing deal

Rediff.com1 Mar 2007

PPD Inc has acquired exclusive worldwide license to develop, manufacture and market Ranbaxy's cholesterol lowering novel statin.

Ranbaxy woes continue to dog Sun Pharma

Ranbaxy woes continue to dog Sun Pharma

Rediff.com29 Oct 2015

The recalled drugs were manufactured and distributed in the US by Ohm Laboratories.

Ranbaxy stock nosedives 20% on USFDA restrictions

Ranbaxy stock nosedives 20% on USFDA restrictions

Rediff.com24 Jan 2014

Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market from its Toansa plant in Punjab.

Daiichi-Ranbaxy row: HC orders attachment of assets

Daiichi-Ranbaxy row: HC orders attachment of assets

Rediff.com26 Feb 2018

The court also restrained RHC Holdings from operating its bank accounts except for payment of salaries and statutory dues till March 23, the next date of hearing.

RPG Life eyes allies to enter US market

RPG Life eyes allies to enter US market

Rediff.com15 Jun 2007

RPG Life already has marketing tie-ups with Israel's drug major Teva for the EU market and with the US-based Apotex for the Canadian market.

Ranbaxy gets FDA nod for hypertension drug

Ranbaxy gets FDA nod for hypertension drug

Rediff.com26 Apr 2004

Ranbaxy Laboratories Ltd has received the US Food and Drug Administration approval to market Fosinopril sodium tablets in the United States.

After US, Germany bans export of Ranbaxy's Dewas plant drugs

After US, Germany bans export of Ranbaxy's Dewas plant drugs

Rediff.com3 Dec 2014

The company did not comply to the 'good manufacturing practice' norms.

Ranbaxy gets USFDA nod for Atenolol tabs

Ranbaxy gets USFDA nod for Atenolol tabs

Rediff.com2 Jan 2007

Ranbaxy Pharmaceuticals Inc said on Tuesday it has received US Food and Drug Administration's approval for manufacturing and marketing cardiovascular drug -- Atenolol tablets in the US.

Rosier year-end seen for Indian pharma, thanks to faster US approvals

Rosier year-end seen for Indian pharma, thanks to faster US approvals

Rediff.com12 Oct 2015

Rosier year-end seen for Indian pharma thanks to faster US approvals.

US sees red over sindoor

US sees red over sindoor

Rediff.com19 Dec 2007

Indian women may consider it sacred to adorn 'Sindoor' (vermilion) on their foreheads, but the United States government has warned against using a particular brand of this toxic 'red powder' due to high lead content.

3 Indian firms get FDA nod for sleep disorder drug

3 Indian firms get FDA nod for sleep disorder drug

Rediff.com26 Apr 2007

Ranbaxy Laboratories, Dr Reddy's Laboratories and Sun Pharma's US subsidiary Caraco Pharmaceuticals are among the 13 generic manufacturers to get first generic approvals from the US Food and Drug Administration to manufacture and market generic versi

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

US FDA conducts surprise inspection of Dr Reddy's Vizag plant

Rediff.com20 Nov 2014

The FDA has been tightening its monitoring of Indian pharma majors over compliance issues. Surprise plant inspections and import alerts have been frequent outcomes

Eli Lilly sues Sun Pharma over patent

Eli Lilly sues Sun Pharma over patent

Rediff.com2 Apr 2007

Eli Lilly and Company, the US-based multinational pharmaceutical major, has sued Sun Pharmaceuticals in the US, alleging the company infringed its patent on Gemzar, a blockbuster cancer drug.

Ranbaxy recalls 7.3 cr Gabapentin tablets

Ranbaxy recalls 7.3 cr Gabapentin tablets

Rediff.com16 Nov 2007

In a setback to pharmaceutical major Ranbaxy Laboratories Ltd, the US drug regulator USFDA has directed the company to recall as many as 7.32 crore (73.2 million) Gabapentin tablets of 600 and 800 mg strengths.

Wockhardt gets FDA nod to market painkillers in US

Wockhardt gets FDA nod to market painkillers in US

Rediff.com20 Mar 2007

Wockhardt Ltd said on Tuesday it has got US Food and Drug Administration's approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate and Acetaminophen in the US market.

Wockhardt gets warning letter from USFDA over Waluj plant

Wockhardt gets warning letter from USFDA over Waluj plant

Rediff.com20 Jul 2013

The company had in May announced that the US Food and Drug Administration had issued an import alert on its Waluj facility, which makes injectables and solid dosages.

Dr Reddy's snaps ties with US drug co

Dr Reddy's snaps ties with US drug co

Rediff.com14 May 2007

The $66 million (Rs 272.8 crore) Leiner Health Products is likely to sue DRL for the early divorce (the agreement has lasted only four years) from the alliance.

Sensex recovers by 172 points, Nifty ends at 9,100 on positive global cues

Sensex recovers by 172 points, Nifty ends at 9,100 on positive global cues

Rediff.com28 Mar 2017

Broader market outperformed with the S&P BSE Midcap index adding 0.7%, while S&P BSE Smallcap index gained 0.6%.

Indian pharma majors cash in on off-patent drugs

Indian pharma majors cash in on off-patent drugs

Rediff.com1 May 2007

In comparison, Indian companies received only 23 out of 139 final approvals (16.54 per cent) in the corresponding period in 2006.

Auto gains, IT slips in MFs allocations

Auto gains, IT slips in MFs allocations

Rediff.com15 Jan 2017

Money managers have turned cautious about the technology space.

SC to hear plea against Ranbaxy on June 24

SC to hear plea against Ranbaxy on June 24

Rediff.com17 Jun 2013

The case was earlier heard by a different vacation bench which had on June 10 asked Sharma to substantiate his 'unfounded allegations' that the Indian pharma major was allegedly manufacturing and selling adulterated medicines.

Lupin, Ranbaxy get USFDA nod

Lupin, Ranbaxy get USFDA nod

Rediff.com16 Apr 2007

Lupin Ltd received marketing approval from the US Food and Drug Administration to market its Cefixime oral suspension drug in the US, Ranbaxy Laboratories has received approval to market two strengths of Cefprozil tablets and Cefprozil powder.

Regulator finds procedural lapses at Wockhardt's US facility

Regulator finds procedural lapses at Wockhardt's US facility

Rediff.com3 Jun 2014

The FDA had imposed a ban on the company's Waluj plant in May.

New Jersey: Feds conduct search at Ranbaxy HQ

New Jersey: Feds conduct search at Ranbaxy HQ

Rediff.com15 Feb 2007

Agents from the US Food and Drug Administration apparently locked down the US headquarters of the Indian pharmaceutical major as well.

US regulator fast-tracks approval for Wockhardt drugs

US regulator fast-tracks approval for Wockhardt drugs

Rediff.com1 Sep 2014

These drugs will be entering in their global Phase -3 clinical trials early next year.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

Ranbaxy to market Cefprozil in USA

Ranbaxy to market Cefprozil in USA

Rediff.com15 Dec 2006

Ranbaxy Laboratories will soon join the select club of Indian pharmaceutical majors and have a share in the $76.6 million generics market for anti-infective Cefprozil tablets in the US.

Compliance worries hit shares in India's top two drugmakers

Compliance worries hit shares in India's top two drugmakers

Rediff.com9 Nov 2015

Credit Suisse analysts cut their rating on Sun Pharma stock to 'neutral' from 'outperform

Wockhardt to launch new antibiotic in US next week

Wockhardt to launch new antibiotic in US next week

Rediff.com2 Jun 2006

The company has already received approval from the US Food & Drug Administration for marketing clarithromycin tablets.

Lupin gets USFDA nod to market HIV drug in US

Lupin gets USFDA nod to market HIV drug in US

Rediff.com10 Dec 2013

The company has received final approval from the US Food and Drug Administration for its Abacavir Sulfate Lamivudine, and Zidovudine Tablets, Lupin Ltd said in a statement.

USFDA approvals fail to enthuse Indian firms

USFDA approvals fail to enthuse Indian firms

Rediff.com4 Jun 2007

In April, Mumbai-based pharmaceutical company Wockhardt announced it had received five marketing approvals for its generic medicines, versions of those that have gone off patents, from the US Food and Drug Administration in five weeks.